Dexmedetomidine alleviates acute lung injury in mice by regulating Toll-like receptor 4/aconitate decarboxylase 1 immune metabolism coupling in macrophages: an experimental study

Li Kefeng, Xu Fang

PDF(2739 KB)
PDF(2739 KB)
Journal of Chongqing Medical University ›› 2025, Vol. 50 ›› Issue (01) : 65-71. DOI: 10.13406/j.cnki.cyxb.003694
Basic research

Dexmedetomidine alleviates acute lung injury in mice by regulating Toll-like receptor 4/aconitate decarboxylase 1 immune metabolism coupling in macrophages: an experimental study

Author information +
History +

Abstract

Objective To investigate the effect of dexmedetomidine(DEX) on lung injury in mice by regulating Toll-like receptor-4 (TLR4)/aconitate decarboxylase 1(ACOD1) immune metabolism coupling in macrophages. Methods RAW264.7 cells were divided into control group,LPS group,and LPS+DEX group,and Western blot and ELISA were used to measure the expression levels of TLR4,ACOD1,and proinflammatory cytokines. C57 BL/6 mice were divided into control group,cecal ligation and puncture(CLP) group,and CLP+DEX group,and experiments were conducted to observe the 7-day survival rate and lung injury of mice,as well as the expression levels of TLR4 and ACOD1 in lung tissue and the expression levels of proinflammatory cytokines in alveolar macrophages and peripheral blood. Subsequently,Acod1 systemic knockout(Acod1-/- ) mice were used to observe the condition of lung injury after CLP+DEX treatment and the changes after CLP+DEX treatment in wild-type(WT) mice. Finally,bone marrow-derived macrophages(BMDMs) were extracted from WT and Acod1-/- mice to measure the expression level of inducible nitric oxide synthase(iNOS) in macrophages. Results After LPS stimulation of RAW264.7 cells,there were increases in the expression levels of TLR4,iNOS,tumor necrosis factor-α(TNF-α),and interleukin-6(IL-6),which were reduced after DEX treatment. In vivo experiments showed that DEX treatment reduced the 7-day mortality rate,diffuse alveolar injury,pulmonary edema,and the expression levels of the proinflammatory cytokines TNF-α and IL-6 in peripheral blood in mice with CLP-induced acute respiratory distress syndrome/acute lung injury,and it also reduced the expression level of iNOS in lung tissue and alveolar macrophages. In addition,DEX reduced the expression level of TLR4 in the lung tissue of CLP mice. Knockout of the Acod1 gene reversed the therapeutic effect of DEX,aggravated lung injury,and increased the expression of iNOS in BMDMs. Conclusion Dexmedetomidine can regulate TLR4/ACOD1 immune metabolism coupling in macrophages,reduce the release of inflammatory cytokines in macrophages after LPS stimulation,and alleviate acute lung injury in mice.

Key words

acute respiratory distress syndrome / macrophages / dexmedetomidine / aconitate decarboxylase 1

Cite this article

Download Citations
Li Kefeng , Xu Fang. Dexmedetomidine alleviates acute lung injury in mice by regulating Toll-like receptor 4/aconitate decarboxylase 1 immune metabolism coupling in macrophages: an experimental study. Journal of Chongqing Medical University. 2025, 50(01): 65-71 https://doi.org/10.13406/j.cnki.cyxb.003694

References

1
ARDS Definition Task Force Ranieri VM Rubenfeld GD,et al. Acute respiratory distress syndrome:the Berlin Definition[J]. JAMA2012307(23):2526-2533.
2
Glass CK Natoli G. Molecular control of activation and priming in macrophages[J]. Nat Immunol201617(1):26-33.
3
Ryan DG O’Neill LAJ. Krebs cycle reborn in macrophage immunometabolism[J]. Annu Rev Immunol202038:289-313.
4
Shan WJ Cui J Song YJ,et al. Itaconate as a key player in cardiovascular immunometabolism[J]. Free Radic Biol Med2024219:64-75.
5
Wu RL Chen F Wang N,et al. ACOD1 in immunometabolism and disease[J]. Cell Mol Immunol202017(8):822-833.
6
Wu RL Liu J Tang DL,et al. The dual role of ACOD1 in inflammation[J]. J Immunol2023211(4):518-526.
7
Sun HQ Hu HY Xu XP,et al. Protective effect of dexmedetomidine in cecal ligation perforation-induced acute lung injury through HMGB1/RAGE pathway regulation and pyroptosis activation[J]. Bioengineered202112(2):10608-10623.
8
Borger M von Haefen C Bührer C,et al. Cardioprotective effects of dexmedetomidine in an oxidative-stress in vitro model of neonatal rat cardiomyocytes[J]. Antioxidants202312(6):1206.
9
Zhou Y Du XY Wang QY,et al. Dexmedetomidine protects against airway inflammation and airway remodeling in a murine model of chronic asthma through TLR4/NF-κB signaling pathway[J]. Mediators Inflamm20232023:3695469.
10
Mikawa K Nishina K Takao Y,et al. ONO-1714,a nitric oxide synthase inhibitor,attenuates endotoxin-induced acute lung injury in rabbits[J]. Anesth Analg200397(6):1751-1755.
11
Wu RL Kang R Tang DL. Mitochondrial ACOD1/IRG1 in infection and sterile inflammation[J]. J Intensive Med20222(2):78-88.
12
Zheng YY Gao YY Zhu WR,et al. Advances in molecular agents targeting toll-like receptor 4 signaling pathways for potential treatment of sepsis[J]. Eur J Med Chem2024268:116300.
13
Kashfi K Kannikal J Nath N. Macrophage reprogramming and cancer therapeutics:role of iNOS-derived NO[J]. Cells202110(11):3194.
14
Locati M Curtale G Mantovani A. Diversity,mechanisms,and significance of macrophage plasticity[J]. Annu Rev Pathol202015:123-147.
15
Han DW Oh JE Lim BJ,et al. Dexmedetomidine attenuates subarachnoid hemorrhage-induced acute lung injury through regulating autophagy and TLR/NFκB signaling pathway[J]. Korean J Anesthesiol202275(6):518-529.
16
Chen SY Wu JJ Yang L,et al. Dexmedetomidine leads to the mitigation of myocardial ischemia/reperfusion-induced acute lung injury in diabetic rats via modulation of hypoxia-inducible factor-1α[J]. Braz J Cardiovasc Surg202237(3):370-379.
17
Han QQ Li XY Wang YX. Dexmedetomidine attenuates lipopolysaccharide-induced inflammation through macrophageal IL-10 expression following α7 nAchR activation[J]. Int Immunopharmacol2022109:108920.
18
Ye XJ Xu HL Xu Y. Dexmedetomidine alleviates intestinal barrier dysfunction and inflammatory response in mice via suppressing TLR4/MyD88/NF-κB signaling in an experimental model of ulcerative colitis[J]. Folia Histochem Cytobiol202260(4):311-322.
19
Chen SY Wu JJ Li AM,et al. Effect and mechanisms of dexmedetomidine combined with macrophage migration inhibitory factor inhibition on the expression of inflammatory factors and AMPK in mice[J]. Clin Exp Immunol2023212(1):61-69.

Comments

PDF(2739 KB)

Accesses

Citation

Detail

Sections
Recommended

/